S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
NASDAQ:AZTA

Azenta (AZTA) Stock Price, News & Analysis

$60.28
+0.85 (+1.43%)
(As of 03/28/2024 ET)
Today's Range
$59.40
$61.17
50-Day Range
$57.82
$67.51
52-Week Range
$36.01
$69.16
Volume
367,329 shs
Average Volume
522,661 shs
Market Capitalization
$3.36 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$74.67

Azenta MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
23.9% Upside
$74.67 Price Target
Short Interest
Bearish
7.57% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.83mentions of Azenta in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
89.29%
From $0.28 to $0.53 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.58 out of 5 stars

Medical Sector

760th out of 939 stocks

Special Industry Machinery, Not Elsewhere Classified Industry

8th out of 13 stocks

AZTA stock logo

About Azenta Stock (NASDAQ:AZTA)

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

AZTA Stock Price History

AZTA Stock News Headlines

Azenta (NASDAQ:AZTA) Rating Reiterated by Needham & Company LLC
Decoding 7 Analyst Evaluations For Azenta
Your Money is Not Safe
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
In-Depth Examination Of 5 Analyst Recommendations For Azenta
Your Money is Not Safe
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
Strong Buy Rating for Azenta, Inc. Amid Growth and Strategic Initiatives
Azenta: Q1 Earnings Insights
Preview: Azenta's Earnings
Natural gas utility Spire names new chairman
Azenta to Host Investor Day on March 14, 2024
See More Headlines
Receive AZTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/07/2024
Today
3/29/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Special industry machinery, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:AZTA
Employees
3,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$74.67
High Stock Price Target
$79.00
Low Stock Price Target
$70.00
Potential Upside/Downside
+23.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-14,260,000.00
Pretax Margin
-4.75%

Debt

Sales & Book Value

Annual Sales
$665.07 million
Cash Flow
$1.69 per share
Book Value
$42.10 per share

Miscellaneous

Free Float
54,778,000
Market Cap
$3.36 billion
Optionable
Optionable
Beta
1.54
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Stephen S. Schwartz (Age 65)
    CEO, President & Director
    Comp: $1.05M
  • Mr. Robin Vacha (Age 48)
    Senior Vice President of Global Operations
    Comp: $533.35k
  • Mr. Jason W. Joseph (Age 53)
    Senior VP, General Counsel & Corporate Secretary
    Comp: $544.13k
  • Mr. Herman Cueto (Age 50)
    Executive VP & CFO
  • Ms. Violetta Hughes (Age 52)
    VP & Chief Accounting Officer
  • Mr. Michael Paulo
    VP and Chief Information & Digital Officer
  • Sara Silverman
    Head of Investor Relations & Corporate Communications
  • Mr. John E. O'Brien (Age 54)
    Senior Vice President of Corporate Development
  • Ms. Olga Pirogova (Age 50)
    Senior VP & Chief HR Officer
  • Mr. J. Robert Woodward
    Senior Vice President of Global Quality & Regulatory

AZTA Stock Analysis - Frequently Asked Questions

Should I buy or sell Azenta stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AZTA shares.
View AZTA analyst ratings
or view top-rated stocks.

What is Azenta's stock price target for 2024?

4 equities research analysts have issued 12-month price objectives for Azenta's shares. Their AZTA share price targets range from $70.00 to $79.00. On average, they expect the company's stock price to reach $74.67 in the next twelve months. This suggests a possible upside of 23.9% from the stock's current price.
View analysts price targets for AZTA
or view top-rated stocks among Wall Street analysts.

How have AZTA shares performed in 2024?

Azenta's stock was trading at $65.14 on January 1st, 2024. Since then, AZTA shares have decreased by 7.5% and is now trading at $60.28.
View the best growth stocks for 2024 here
.

When is Azenta's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our AZTA earnings forecast
.

How were Azenta's earnings last quarter?

Azenta, Inc. (NASDAQ:AZTA) released its quarterly earnings results on Wednesday, February, 7th. The company reported $0.02 earnings per share (EPS) for the quarter. The company had revenue of $154.32 million for the quarter, compared to analysts' expectations of $151.86 million. Azenta had a negative net margin of 2.92% and a positive trailing twelve-month return on equity of 0.49%.

Is Azenta a good dividend stock?

Azenta (NASDAQ:AZTA) pays an annual dividend of $0.10 per share and currently has a dividend yield of 0.00%.
Read our dividend analysis for AZTA.

What guidance has Azenta issued on next quarter's earnings?

Azenta updated its FY 2024 earnings guidance on Thursday, March, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $696.0 million-$718.0 million, compared to the consensus revenue estimate of $703.6 million.

Who are Azenta's major shareholders?

Azenta's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.13%), Vanguard Group Inc. (10.13%), Dimensional Fund Advisors LP (4.01%), Norges Bank (3.88%), Allspring Global Investments Holdings LLC (2.97%) and GW&K Investment Management LLC (2.76%). Insiders that own company stock include David C Gray, Jesus Linda De, Kimberly Crowley, Lindon G Robertson and Matthew Mcmanus.
View institutional ownership trends
.

How do I buy shares of Azenta?

Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AZTA) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners